Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer

Journal of Clinical Oncology

Volumn 16, Issue 3, 1998, Pages 1022-1029

  Hayman, James A ^a   Hillner, Bruce E ^a   Harris, Jay R ^a   Weeks, Jane C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; LIFE EXPECTANCY; MODEL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

EID: 0031934333     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.3.1022     Document Type: Article

References (27)

1. Wingo PA, Tong T, Bolden S, et al: Cancer statistics, 1995. CA Cancer J Clin 45:8-30, 1995
2. Clark RM, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. J Natl Cancer Inst 88:1659-1664, 1996
3. Veronesi U, Luini A, Del Vecchio M, et al: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587-1591, 1993
4. Fisher B, Anderson S, Redmond CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995
5. Liljegren G, Holmberg L, Adami H-O, et al: Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five year results of a randomized trial. J Natl Cancer Inst 86:717-722, 1994
6. Forrest PA, Stewart HJ, Everington D, et al: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of Scottish trial. Lancet 348:708-713, 1996
7. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 333:1444-1455, 1995
8. Larson D, Weinstein M, Goldberg I, et al: Edema of the arm as a function of the extent of axillary surgery in patients with stage I and II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12:1575-1582, 1986
9. Pierce S, Recht A, Lingos T, et al: Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23:915-923, 1992
10. Boice JD Jr, Harvey EB, Blettner M, et al: Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785, 1992
11. Kattlove H, Liberati A, Keeler E, et al: Benefits and costs of screening and treatment for early breast cancer: Development of a basic benefit package. JAMA 273:142-148, 1995
12. Sonnenberg FA, Beck JR: Markov models in medical decision making: A practical guide. Med Decis Making 13:322-338, 1993
13. Hillner BE, Smith TJ: Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. N Engl J Med 324:160-168, 1991
14. McCready DR, Chapman JAC, Wall JL, et al: Characteristic of local recurrence following lumpectomy for breast cancer. Cancer Invest 12:568-573, 1994
15. Schnitt SJ, Hayman J, Gelman R, et al: A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77:1094-1100, 1996
16. von Neumann J, Morgenstern O: Theory of Games and Economic Behavior. Princeton, NJ. Princeton University, 1947
17. Hayman JA, Fairclough DL, Harris JR, et al: Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol 15:1252-1260, 1997
18. Weinstein MC, Siegel JE, Gold MR, et al: Recommendations of the panel of cost-effectiveness in health and medicine. JAMA 276:1253-1258, 1996
19. Hillner BE, Bear HD, Fajardo LL: Estimating the cost-effectiveness of stereotaxic biopsy for non-palpable breast abnormalities: A decision analysis model. Acad Radiol 3:351-360, 1996
20. Hillner BE: The use of a micro-simulation to guide clinical evaluation of a new imaging technology: The case of sestamibi imaging and non-palpable breast abnormalities. J Nucl Med (in press)
21. Luce BR, Manning WG, Siegel JE, et al: Estimating costs in cost-effectiveness analysis, in Gold MR, Siegel JE, Russell LB, et al (eds): Cost-Effectiveness in Health and Medicine. New York, NY, Oxford University, 1996, pp 176-213
22. US. Bureau of the Census: Current Population Reports. Money Income in the United States: 1995 (With Separate Data on Valuation of Noncash Benefits). Washington, DC, United States Government Printing Office, 1996, pp 60-193
23. Garner TI, Dardis R: Cost-effectiveness analysis of end-stage renal disease treatments. Med Care 25:25-34, 1987
24. Smith TJ, Hillner BE, Desch CE: Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis. J Natl Cancer Inst 85:1460-1474, 1993
25. 1996 Geographic Practice Cost Indices by Medicare Carrier and Locality. Fed Reg 60:63353, 1996
26. Liljegren G, Karlsson G, Bergh J, et al: The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial. Ann Oncol 8:757-763, 1997
27. Russell LB, Gold MR, Siegel JE, et al: The role of cost-effectiveness analysis in health and medicine. JAMA 276:1172-1177, 1996